One-year follow-up of clinical convergence measures in children enrolled in the Convergence Insufficiency Treatment Trial-Attention and Reading Trial.
convergence insufficiency
exophoria
orthoptics
vision therapy
Journal
Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)
ISSN: 1475-1313
Titre abrégé: Ophthalmic Physiol Opt
Pays: England
ID NLM: 8208839
Informations de publication
Date de publication:
14 Aug 2024
14 Aug 2024
Historique:
revised:
29
07
2024
received:
04
05
2024
accepted:
01
08
2024
medline:
14
8
2024
pubmed:
14
8
2024
entrez:
14
8
2024
Statut:
aheadofprint
Résumé
To assess the long-term stability of clinical measures of convergence (near point of convergence [NPC] and positive fusional vergence [PFV]) in participants enrolled in the Convergence Insufficiency Treatment Trial-Attention and Reading Trial (CITT-ART) who received 16 weeks of office-based vergence/accommodative therapy. A total of 310 children, 9-14 years old, with symptomatic convergence insufficiency were enrolled in CITT-ART. Some 270 completed both their 16-week primary outcome visit followed by a 1-year follow-up visit. Of those 270, 181 (67%) were randomised to the vergence/accommodative therapy. Of the 181 in the vergence/accommodative group, 121 (67%) reported not receiving any additional treatment after the 16-week primary outcome visit. The mean change in NPC, PFV and percentages of children classified by the predetermined success criteria of convergence (normal NPC [<6 cm] and/or improved by ≥4 cm; normal PFV [passing Sheard's criterion and base-out break >15Δ] and/or improved by ≥10Δ) were compared at the 16-week primary outcome visit and 1 year later. Of the 121 who returned for their 1-year follow-up visit, there was no significant change in mean adjusted NPC (reduction of -0.2 cm; 95% CI: -1.0 to 0.5 cm) at 1 year. There was a statistically significant decrease in mean-adjusted PFV (-4.7∆; 95% CI: -6.5 to -2.8Δ) at 1 year. There were similar percentages of participants classified as 'normal' (p = 0.30), 'normal and/or improved' (p > 0.50) and 'normal and improved' (p > 0.14) based on NPC and PFV at the 1-year visit compared with the 16-week primary outcome visit. The improvements in NPC and PFV following 16 weeks of vergence/accommodative therapy (with no reported additional treatment thereafter) in children with symptomatic convergence insufficiency persisted 1-year post-treatment.
Banques de données
RefSeq
['NCT02207517']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Eye Institute of National Institutes of Health, Department of Health and Human Services
ID : 5U10EY022586
Organisme : National Eye Institute of National Institutes of Health, Department of Health and Human Services
ID : 5U10EY022587
Organisme : National Eye Institute of National Institutes of Health, Department of Health and Human Services
ID : 5U10EY022591
Organisme : National Eye Institute of National Institutes of Health, Department of Health and Human Services
ID : 5U10EY022592
Organisme : National Eye Institute of National Institutes of Health, Department of Health and Human Services
ID : 5U10EY022594
Organisme : National Eye Institute of National Institutes of Health, Department of Health and Human Services
ID : 5U10EY022595
Organisme : National Eye Institute of National Institutes of Health, Department of Health and Human Services
ID : 5U10EY022596
Organisme : National Eye Institute of National Institutes of Health, Department of Health and Human Services
ID : 5U10EY022599
Organisme : National Eye Institute of National Institutes of Health, Department of Health and Human Services
ID : 5U10EY022600
Organisme : National Eye Institute of National Institutes of Health, Department of Health and Human Services
ID : 5U10EY022601
Investigateurs
Jeffrey Cooper
(J)
Erica Schulman
(E)
Kimberly Hamian
(K)
Danielle Iacono
(D)
Steven Larson
(S)
Valerie Leung
(V)
Sara Meeder
(S)
Elaine Ramos
(E)
Steven Ritter
(S)
Audra Steiner
(A)
Alexandria Stormann
(A)
Marilyn Vricella
(M)
Xiaoying Zhu
(X)
Susanna Tamkins
(S)
Naomi Aguilera
(N)
Elliot Brafman
(E)
Hilda Capo
(H)
Kara Cavuoto
(K)
Isaura Crespo
(I)
Monica Dowling
(M)
Kristie Draskovic
(K)
Miriam Farag
(M)
Vicky Fischer
(V)
Sara Grace
(S)
Ailen Gutierrez
(A)
Carolina Manchola-Orozco
(C)
Maria Martinez
(M)
Craig McKeown
(C)
Carla Osigian
(C)
Leslie Small
(L)
Natalie Townsend
(N)
Michael Gallaway
(M)
Mark Boas
(M)
Christine Calvert
(C)
Tara Franz
(T)
Amanda Gerrouge
(A)
Donna Hayden
(D)
Erin Jenewein
(E)
Zachary Margolies
(Z)
Shivakhaami Meiyeppen
(S)
Jenny Myung
(J)
Karen Pollack
(K)
Mitchell Scheiman
(M)
Ruth Shoge
(R)
Andrew Tang
(A)
Noah Tannen
(N)
Lynn Trieu
(L)
Luis Trujillo
(L)
Marjean Kulp
(M)
Michelle Buckland
(M)
Allison Ellis
(A)
Jennifer Fogt
(J)
Catherine McDaniel
(C)
Taylor McGann
(T)
Ann Morrison
(A)
Shane Mulvihill
(S)
Adam Peiffer
(A)
Maureen Plaumann
(M)
Gil Pierce
(G)
Julie Preston
(J)
Kathleen Reuter
(K)
Nancy Stevens
(N)
Jake Teeny
(J)
Andrew Toole
(A)
Douglas Widmer
(D)
Aaron Zimmerman
(A)
Susan Cotter
(S)
Carmen Barnhardt
(C)
Eric Borsting
(E)
Angela Chen
(A)
Raymond Chu
(R)
Kristine Huang
(K)
Susan Parker
(S)
Dashaini Retnasothie
(D)
Judith Wu
(J)
Richard Hertle
(R)
Penny Clark
(P)
Kelly Culp
(K)
Kathy Fraley
(K)
Drusilla Grant
(D)
Nancy Hanna
(N)
Stephanie Knox
(S)
William Lawhon
(W)
Lan Li
(L)
Sarah Mitcheff
(S)
Isabel Ricker
(I)
Tawna Roberts
(T)
Casandra Solis
(C)
Palak Wall
(P)
Samantha Zaczyk
(S)
Kristine Hopkins
(K)
Wendy Marsh-Tootle
(W)
Michelle Bowen
(M)
Terri Call
(T)
Kristy Domnanovich
(K)
Marcela Frazier
(M)
Nicole Guyette
(N)
Oakley Hayes
(O)
John Houser
(J)
Sarah Lee
(S)
Jenifer Montejo
(J)
Tamara Oechslin
(T)
Christian Spain
(C)
Candice Turner
(C)
Katherine Weise
(K)
Rachel Coulter
(R)
Deborah Amster
(D)
Annette Bade
(A)
Surbhi Bansal
(S)
Laura Falco
(L)
Gregory Fecho
(G)
Katherine Green
(K)
Gabriela Irizarry
(G)
Jasleen Jhajj
(J)
Nicole Patterson
(N)
Jacqueline Rodena
(J)
Yin Tea
(Y)
Julie Tyler
(J)
Dana Weiss
(D)
Lauren Zakaib
(L)
Ingryd Lorenzana
(I)
Yesena Meza
(Y)
Ryan Mann
(R)
Mariana Quezada
(M)
Scott Rein
(S)
Indre Rudaitis
(I)
Susan Stepleton
(S)
Beata Wajs
(B)
Mariana Quezada
(M)
Maryann Redford
(M)
Mitchell Scheiman
(M)
G Lynn Mitchell
(GL)
Susan Cotter
(S)
Richard Hertle
(R)
Marjean Kulp
(M)
Maryann Redford
(M)
Carolyn Denton
(C)
Eugene Arnold
(E)
Eric Borsting
(E)
Christopher Chase
(C)
Carolyn Denton
(C)
Sharyl Wee
(S)
Katlynn Dahl-Leonard
(K)
Kenneth Powers
(K)
Amber Alaniz
(A)
Marie Diener-West
(M)
William V Good
(WV)
David Grisham
(D)
Christopher J Kratochvil
(CJ)
Dennis Revicki
(D)
Jeanne Wanzek
(J)
Mitchell Scheiman
(M)
Karen Pollack
(K)
Susan Cotter
(S)
Marjean Kulp
(M)
G Lynn Mitchell
(GL)
Mustafa Alrahem
(M)
Julianne Dangelo
(J)
Jordan Hegedus
(J)
Ian Jones
(I)
Lisa A Jones-Jordan
(LA)
Alexander Junglas
(A)
Jihyun Lee
(J)
Jadin Nettles
(J)
Curtis Mitchell
(C)
Mawada Osman
(M)
Gloria Scott-Tibbs
(G)
Loraine Sinnott
(L)
Chloe Teasley
(C)
Victor Vang
(V)
Robin Varghese
(R)
Informations de copyright
© 2024 The Author(s). Ophthalmic and Physiological Optics published by John Wiley & Sons Ltd on behalf of College of Optometrists.
Références
Scheiman M, Kulp MT, Cotter SA, Lawrenson JG, Wang L, Li T. Interventions for convergence insufficiency: a network meta‐analysis. Cochrane Database Syst Rev. 2020;12:CD006768. https://doi.org/10.1002/14651858.CD006768
Convergence Insufficiency Treatment Trial Study Group. Randomized clinical trial of treatments for symptomatic convergence insufficiency in children. Arch Ophthalmol. 2008;126:1336–1349.
CITT‐ART Investigator Group. Treatment of symptomatic convergence insufficiency in children enrolled in the Convergence Insufficiency Treatment Trial‐Attention and Reading Trial: a randomized clinical trial. Optom Vis Sci. 2019;96:825–835.
Pantano F. Orthoptic treatment of convergence insufficiency: a two year follow‐up report. Am Orthopt J. 1982;32:73–80.
Cohen AH, Soden R. Effectiveness of visual therapy for convergence insufficiencies for an adult population. J Am Optom Assoc. 1984;55:491–494.
Wick B. Vision training for presbyopic nonstrabismic patients. Am J Optom Physiol Opt. 1977;54:244–247.
Shin HS, Park SC, Maples WC. Effectiveness of vision therapy for convergence dysfunctions and long‐term stability after vision therapy. Ophthalmic Physiol Opt. 2011;31:180–189.
Convergence Insufficiency Treatment Trial Study Group. Long‐term effectiveness of treatments for symptomatic convergence insufficiency in children. Optom Vis Sci. 2009;86:1096–1103.
CITT‐ART Investigator Group. Effect of vergence/accommodative therapy on reading in children with convergence insufficiency: a randomized clinical trial. Optom Vis Sci. 2019;96:836–849.
Scheiman M, Mitchell GL, Cotter SA, Kulp M, Chase C, Borsting E, et al. Convergence Insufficiency Treatment Trial—Attention and Reading Trial (CITT‐ART): design and methods. Vis Dev Rehabil. 2015;1:214–228.
Scheiman M, Mitchell GL, Cotter S, Cooper J, Kulp M, Rouse M, et al. A randomized clinical trial of treatments for convergence insufficiency in children. Arch Ophthalmol. 2005;123:14–24.